former fda commissioner on potential second wave of coronavirus cases
Published 4 years ago • 48K plays • Length 6:11Download video MP4
Download video MP3
Similar videos
-
3:32
former fda chief on concerns of potential second coronavirus wave
-
3:46
expect a second wave of covid-19 in the fall: former fda chief gottlieb
-
6:56
hard to see what's going to stop the spread: fmr. fda chief
-
3:38
states untouched by coronavirus could be more vulnerable to second wave: former fda chief
-
4:42
could see coronavirus cases grow dramatically in the fall: former fda commissioner
-
5:13
dr. scott gottlieb on promising new cancer drug data: 'the future is here'
-
9:37
‘excellent news’: fda to approve covid vaccine boosters for ages 12-15
-
2:09
ftc probes consumer facing companies over 'surveillance pricing'
-
36:31
watch live: former fda officials dr. scott gottlieb and dr. luciana borio in cnbc’s healthy returns
-
4:07
we are now in the second wave: fmr. fda chief scott gottlieb
-
7:28
coronavirus: congress must act fast to mitigate the pandemic, fda commissioner says
-
3:43
universal masking cuts the rate of covid-19 transmission: fmr. fda commissioner
-
6:19
nearly half of the u.s. will likely have had covid-19 by the end of 2020: former fda chief
-
2:27
u.s. likely won't shut down again even if cases rise after reopening: former fda chief
-
6:59
dexamethasone finding is significant: fmr. fda chief
-
8:17
texas reopened a lot of things quickly, may dial it back: former fda commissioner
-
5:11
coronavirus is likely more widespread in china than statistics suggest: former fda commissioner
-
5:02
coronavirus: there will be a coronavirus therapeutic very soon, former fda head scott gottlieb says
-
5:53
covid will likely become a 'seasonal pandemic': former fda commissioner
-
4:32
level of covid-19 spread puts u.s. in 'precarious' situation: former fda chief
-
3:52
former fda chief scott gottlieb on u.s. surpassing 100,000 daily covid-19 cases two days in a row
-
6:29
coronavirus: children are not impervious to this virus, fmr. fda chief says